Financhill
Back

BioXcel Therapeutics Vs. Kinsale Capital Group Industry Stock Comparison

Sell
13

BTAI
BioXcel Therapeutics

Last Price:
2.12
Seasonality Move:
-4.74%
Buy
53

KNSL
Kinsale Capital Group

Last Price:
385.75
Seasonality Move:
22.12%
Sell
13
BioXcel Therapeutics (BTAI) is a Sell

Is BioXcel Therapeutics a Buy, Sell or Hold?

  • The current BioXcel Therapeutics [BTAI] share price is $2.12. The Score for BTAI is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • BTAI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
53
Kinsale Capital Group (KNSL) is a Buy

Is Kinsale Capital Group a Buy, Sell or Hold?

  • The current Kinsale Capital Group [KNSL] share price is $386.07. The Score for KNSL is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • KNSL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BTAI Stock Price Chart

What is BioXcel Therapeutics's stock price today?

  • The BioXcel Therapeutics share price today is $2.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing selling pressure, which indicates risk of future bearish movement.

KNSL Stock Price Chart

What is Kinsale Capital Group's stock price today?

  • The Kinsale Capital Group share price today is $386.07
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KNSL is experiencing selling pressure, which indicates risk of future bearish movement.

BTAI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 29.43 Sell
Chaikin Money Flow: -678017 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.46 - 2.8) Sell
Bollinger Bands (100): (2.55 - 3.25) Sell

KNSL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -24.7 Sell
Relative Strength Index (14 RSI): 35.32 Sell
Chaikin Money Flow: -135517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (389.43 - 462.97) Sell
Bollinger Bands (100): (368.18 - 498.5) Sell

BTAI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.47 Sell
20-day SMA: 2.63 Sell
50-day SMA: 2.76 Sell
200-day SMA: 3.56 Sell
8-day EMA: 2.44 Sell
20-day EMA: 2.57 Sell
50-day EMA: 2.74 Sell
200-day EMA: 5.35 Sell

KNSL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 378.96 Buy
20-day SMA: 420.2 Sell
50-day SMA: 471.04 Sell
200-day SMA: 409.36 Sell
8-day EMA: 391.81 Sell
20-day EMA: 414.94 Sell
50-day EMA: 440 Sell
200-day EMA: 409.58 Sell

BioXcel Therapeutics Earnings Growth & BTAI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.34 per share, and an increase next year of $1.16 per share.

Kinsale Capital Group Earnings Growth & KNSL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.78 per share, an increase next quarter of $0.67 per share, an increase this year of $2.79 per share, and an increase next year of $2.61 per share.

BioXcel Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kinsale Capital Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):